AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 26-50/58

Authors: Cen, S Khorchid, A Gabor, J Rong, LW Wainberg, MA Kleiman, L
Citation: S. Cen et al., Roles of Pr55(gag) and NCp7 in tRNA(3)(LYS) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1, J VIROLOGY, 74(22), 2000, pp. 10796-10800

Authors: Guan, YJ Whitney, JB Diallo, K Wainberg, MA
Citation: Yj. Guan et al., Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus, J VIROLOGY, 74(19), 2000, pp. 8854-8860

Authors: Liang, C Rong, LW Russell, RS Wainberg, MA
Citation: C. Liang et al., Deletion mutagenesis downstream of the 5 ' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene, J VIROLOGY, 74(14), 2000, pp. 6251-6261

Authors: Shen, N Jette, L Liang, C Wainberg, MA Laughrea, M
Citation: N. Shen et al., Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging, J VIROLOGY, 74(12), 2000, pp. 5729-5735

Authors: Khorchid, A Javanbakht, H Wise, S Halwani, R Parniak, MA Wainberg, MA Kleiman, L
Citation: A. Khorchid et al., Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1, J MOL BIOL, 299(1), 2000, pp. 17-26

Authors: Kang, CY Luo, LZ Wainberg, MA Li, Y
Citation: Cy. Kang et al., Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles, BIOL CHEM, 380(3), 1999, pp. 353-364

Authors: Quan, YD Motakis, D Buckheit, R Xu, ZQ Flavin, MT Parniak, MA Wainberg, MA
Citation: Yd. Quan et al., Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase, ANTIVIR TH, 4(4), 1999, pp. 203-209

Authors: Richard, N Quan, YD Salomon, H Hsu, M Bedard, J Harrigan, PR Rando, R Mansour, T Bowlin, TL Wainberg, MA
Citation: N. Richard et al., Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thiocytidine (dOTC), ANTIVIR TH, 4(3), 1999, pp. 171-177

Authors: Wainberg, MA Miller, MD Quan, YD Salomon, H Mulato, AS Lamy, PD Margot, NA Anton, KE Cherrington, JM
Citation: Ma. Wainberg et al., In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA, ANTIVIR TH, 4(2), 1999, pp. 87-94

Authors: Lin, PF Gonzalez, CJ Griffith, B Friedland, G Calvez, V Ferchal, F Schinazi, RF Shepp, DH Ashraf, AB Wainberg, MA Soriano, V Mellors, JW Colonno, RJ
Citation: Pf. Lin et al., Stavudine resistance: an update on susceptibility following prolonged therapy, ANTIVIR TH, 4(1), 1999, pp. 21-28

Authors: Wainberg, MA
Citation: Ma. Wainberg, The endless tragedy of pediatric AIDS, J HUMAN VIR, 2(1), 1999, pp. 1-2

Authors: Wainberg, MA
Citation: Ma. Wainberg, South Africa must admit that HIV AIDS is its greatest enemy, BR MED J, 318(7199), 1999, pp. 1700-1700

Authors: Germinario, RJ Colby-Germinario, SP Acel, A Chandok, R Davison, K Mak, J Kleiman, L Faust, E Wainberg, MA
Citation: Rj. Germinario et al., Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression, AIDS RES H, 15(9), 1999, pp. 829-836

Authors: Wainberg, MA
Citation: Ma. Wainberg, The need for microbicides: Why aren't women's groups more involved in the fight against AIDS?, AIDS RES H, 15(5), 1999, pp. 405-406

Authors: Hsu, M Cherry, E Quan, Y Richard, N Kleiman, L Wainberg, MA
Citation: M. Hsu et al., Effect of mutations in NC7 on endogenous reverse transcription in HIV-1, LEUKEMIA, 13, 1999, pp. S113-S115

Authors: Richard, N Salomon, H Oliveira, M Rando, R Wainberg, MA
Citation: N. Richard et al., Resistance profiles of (+)2 '-deoxy-3 '-oxa-4 '-thiocytidine and (-)2 '-deoxy-3 '-oxa-4 '-thio-5-fluorocytidine., NUCLEOS NUC, 18(4-5), 1999, pp. 773-778

Authors: Gu, ZX Wainberg, MA Nguyen-Ba, P L'Heureux, L de Muys, JM Rando, RF
Citation: Zx. Gu et al., Anti-HIV-1 activities of 1,3-dioxolane guanine and 2,6-diaminopurine dioxolane, NUCLEOS NUC, 18(4-5), 1999, pp. 891-892

Authors: Machado, J Salomon, H Oliveira, M Tsoukas, C Krayevsky, AA Wainberg, MA
Citation: J. Machado et al., Antiviral activity and resistance profile of phosphazid - A novel prodrug of AZT, NUCLEOS NUC, 18(4-5), 1999, pp. 901-906

Authors: Wainberg, MA
Citation: Ma. Wainberg, Letter from the President, AIDS, 13(6), 1999, pp. 2-2

Authors: Rubsamen-Waigmann, H Huguenel, E Shah, A Paessens, A Ruoff, HJ von Briesen, H Immelmann, A Dietrich, U Wainberg, MA
Citation: H. Rubsamen-waigmann et al., Resistance mutations selected in vivo under therapy with anti-HIV drug HBY097 differ from resistance pattern selected in vitro, ANTIVIR RES, 42(1), 1999, pp. 15-24

Authors: Wainberg, MA
Citation: Ma. Wainberg, A new source of resistance to HIV drugs, J AM MED A, 281(23), 1999, pp. 2169-2170

Authors: de Muys, JM Gourdeau, H Nguyen-Ba, N Taylor, DL Ahmed, PS Mansour, T Locas, C Richard, N Wainberg, MA Rando, RF
Citation: Jm. De Muys et al., Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine, ANTIM AG CH, 43(8), 1999, pp. 1835-1844

Authors: Borkow, G Arion, D Wainberg, MA Parniak, MA
Citation: G. Borkow et al., The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3 '-azido-3 '-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1, ANTIM AG CH, 43(2), 1999, pp. 259-263

Authors: Gu, ZX Wainberg, MA Nguyen-Ba, N L'Heureux, L de Muys, JM Bowlin, TL Rando, RF
Citation: Zx. Gu et al., Mechanism of action and in vitro activity of 1 ',3 '-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants, ANTIM AG CH, 43(10), 1999, pp. 2376-2382

Authors: Genin, P Mamane, Y Kwon, H LePage, C Wainberg, MA Hiscott, J
Citation: P. Genin et al., Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells, VIROLOGY, 261(2), 1999, pp. 205-215
Risultati: 1-25 | 26-50 | 51-58